08:16 AM EST, 02/05/2025 (MT Newswires) -- Aurora Cannabis ( ACB ) rose 17% in U.S. premarket trading on Wednesday after reporting a third-quarter swing to profit, boosted by a higher fair value of its biological assets and strong medical cannabis revenue.

The company said profit from continuing operations was $31.2 million, compared with a loss of $17.1 million in the prior-year period. The profit includes an increase in unrealized gain on changes in fair

value of biological assets of $42.4 million, the company said.

Net revenues rose 37% to $88.2 million, helped by a 51% increase in medical cannabis and plant propagation revenue. Consumer cannabis net revenue declined 15%.

Aurora expects continued revenue growth across its cannabis business in the fourth quarter.

The company's shares were last seen up US$0.62, to US$4.30, in New York trading